Status: Recruiting
Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma
RR001, a cell-based gene therapy administered following chemotherapy cycles for the treatment of patients with locally advanced pancreatic cancer. Phase I /IIa clinical trial (open label and non-randomized) to test the effects (safety \& efficacy) of increasing doses of RR001
Participants needed: 9
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: EIR Biotherapies s.r.l.Updated: Dec 26, 2025Locations: 1
Eligibility criteria
Patients with confirmed pancreatic ductal adenocarcinoma classified as locally a... [+10]
Patient with pancreatic cystic tumor or pancreatic pseudocyst [+19]